# Bio-Path Holdings Inc. (BPTH)

Source: https://www.quantisnow.com/company/BPTH
Generated: 2026-11-10T02:52:43.454Z

- Ticker: BPTH
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- SEC CIK: 0001133818
- Website: biopathholdings.com

## About

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. The company is also developing Liposomal Bcl-2 for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; Liposomal STAT3 that is in preclinical stage for the treatment of pancreatic cancer, non-small cell lung cancer, and AML; and prexigebersen-A for various solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Bellaire, Texas.

## Latest BPTH news and filings

- 2026-08-05 15:20 UTC [SEC Form 253G2 filed by Bio-Path Holdings Inc.](https://www.quantisnow.com/insight/sec-form-253g2-filed-by-bio-path-holdings-inc-6664495)
- 2026-07-16 17:56 UTC [SEC Form 8-K] [Bio-Path Holdings Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year](https://www.quantisnow.com/insight/bio-path-holdings-inc-filed-sec-form-8-k-unregistered-sales-of-6639506)
- 2026-05-26 18:46 UTC [SEC Form 8-K] [SEC Form 8-K filed by Bio-Path Holdings Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-bio-path-holdings-inc-6571894)
- 2026-05-20 20:42 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Bio-Path Holdings Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-bio-path-holdings-inc-6565556)
- 2026-05-15 16:28 UTC [SEC Form NT 10-Q filed by Bio-Path Holdings Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-bio-path-holdings-inc-6556548)
- 2026-04-29 04:15 UTC [SEC Form QUALIF filed by Bio-Path Holdings Inc.](https://www.quantisnow.com/insight/sec-form-qualif-filed-by-bio-path-holdings-inc-6519744)
- 2026-03-25 18:24 UTC [SEC Form 1-A filed by Bio-Path Holdings Inc.](https://www.quantisnow.com/insight/sec-form-1-a-filed-by-bio-path-holdings-inc-6468645)
- 2026-03-20 01:30 UTC [SEC Form 8-K] [Bio-Path Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year](https://www.quantisnow.com/insight/bio-path-holdings-inc-filed-sec-form-8-k-amendments-to-articles-6462527)
- 2026-02-25 21:44 UTC [SEC Form 1-Z filed by Bio-Path Holdings Inc.](https://www.quantisnow.com/insight/sec-form-1-z-filed-by-bio-path-holdings-inc-6413594)
- 2026-02-24 19:54 UTC [SEC Form 8-K] [Bio-Path Holdings Inc. filed SEC Form 8-K: Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year](https://www.quantisnow.com/insight/bio-path-holdings-inc-filed-sec-form-8-k-changes-in-control-6409564)
- 2026-01-13 16:47 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Bio-Path Holdings Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-bio-path-holdings-inc-6347837)
- 2025-11-17 20:07 UTC [SEC Form NT 10-Q filed by Bio-Path Holdings Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-bio-path-holdings-inc-6282741)
- 2025-11-14 17:10 UTC [SEC Form 8-K] [Bio-Path Holdings Inc. filed SEC Form 8-K: Leadership Update, Other Events](https://www.quantisnow.com/insight/bio-path-holdings-inc-filed-sec-form-8-k-leadership-update-other-6279701)
- 2025-10-29 15:40 UTC [SEC Form 8-K] [Bio-Path Holdings Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/bio-path-holdings-inc-filed-sec-form-8-k-leadership-update-6249506)
- 2025-08-14 21:03 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Bio-Path Holdings Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-bio-path-holdings-inc-6166991)
- 2025-08-13 21:27 UTC [SEC Form 8-K] [Bio-Path Holdings Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits](https://www.quantisnow.com/insight/bio-path-holdings-inc-filed-sec-form-8-k-changes-in-registrants-6163814)
- 2025-06-24 12:00 UTC [SEC Form 8-K] [Bio-Path Holdings Inc. filed SEC Form 8-K: Leadership Update, Other Events](https://www.quantisnow.com/insight/bio-path-holdings-inc-filed-sec-form-8-k-leadership-update-other-6096679)
- 2025-06-13 12:35 UTC [Conference Announcement] [Life Sciences Investor Forum: Now Available for Online Viewing](https://www.quantisnow.com/insight/life-sciences-investor-forum-now-available-for-online-viewing-6085246)
- 2025-06-10 18:38 UTC [Conference Announcement] [Life Sciences Investor Forum Agenda Announced for June 11th-12th](https://www.quantisnow.com/insight/life-sciences-investor-forum-agenda-announced-for-june-11th-12th-6080180)
- 2025-06-09 11:00 UTC [Conference Announcement] [Bio-Path Holdings to Present at Life Sciences Virtual Investor Forum](https://www.quantisnow.com/insight/bio-path-holdings-to-present-at-life-sciences-virtual-investor-forum-6077484)
- 2025-06-03 11:00 UTC [Earnings Date] [Bio-Path Holdings Provides Clinical and Operational Update](https://www.quantisnow.com/insight/bio-path-holdings-provides-clinical-and-operational-update-6068782)
- 2025-06-02 20:35 UTC [SEC Form 253G3 filed by Bio-Path Holdings Inc.](https://www.quantisnow.com/insight/sec-form-253g3-filed-by-bio-path-holdings-inc-6067856)
- 2025-05-30 04:15 UTC [SEC Form QUALIF filed by Bio-Path Holdings Inc.](https://www.quantisnow.com/insight/sec-form-qualif-filed-by-bio-path-holdings-inc-6064147)
- 2025-05-22 20:30 UTC [Earnings Date] [Bio-Path Holdings to Host Corporate Update Conference Call on May 29, 2025](https://www.quantisnow.com/insight/bio-path-holdings-to-host-corporate-update-conference-call-on-may-6054697)
- 2025-05-16 20:15 UTC [Amendment: SEC Form 1-A/A filed by Bio-Path Holdings Inc.](https://www.quantisnow.com/insight/amendment-sec-form-1-aa-filed-by-bio-path-holdings-inc-6045352)
- 2025-05-15 20:18 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Bio-Path Holdings Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-bio-path-holdings-inc-6042660)
- 2025-05-02 12:15 UTC [SEC Form 8-K] [Bio-Path Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/bio-path-holdings-inc-filed-sec-form-8-k-other-events-financial-6014910)
- 2025-05-01 11:00 UTC [Bio-Path Holdings Achieves Third Pre-Clinical Milestone Confirming Potential of BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients](https://www.quantisnow.com/insight/bio-path-holdings-achieves-third-pre-clinical-milestone-confirming-potential-of-bp1001-a-6011901)
- 2025-04-29 20:17 UTC [SEC Form 8-K] [Bio-Path Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits](https://www.quantisnow.com/insight/bio-path-holdings-inc-filed-sec-form-8-k-entry-into-a-6007457)
- 2025-04-11 20:28 UTC [SEC Form 1-A filed by Bio-Path Holdings Inc.](https://www.quantisnow.com/insight/sec-form-1-a-filed-by-bio-path-holdings-inc-5985654)
- 2025-04-09 20:15 UTC [SEC Form RW filed by Bio-Path Holdings Inc.](https://www.quantisnow.com/insight/sec-form-rw-filed-by-bio-path-holdings-inc-5982887)
- 2025-03-28 20:13 UTC [SEC Form 8-K] [Bio-Path Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits](https://www.quantisnow.com/insight/bio-path-holdings-inc-filed-sec-form-8-k-entry-into-a-5964853)
- 2025-03-28 12:47 UTC [SEC Form 8-K] [Bio-Path Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/bio-path-holdings-inc-filed-sec-form-8-k-results-of-operations-5964305)
- 2025-03-28 11:00 UTC [Earnings] [Bio-Path Holdings Reports Full Year 2024 Financial Results](https://www.quantisnow.com/insight/bio-path-holdings-reports-full-year-2024-financial-results-5964067)
- 2025-03-27 20:42 UTC [SEC Form 10-K] [SEC Form 10-K filed by Bio-Path Holdings Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-bio-path-holdings-inc-5963486)
- 2025-03-19 11:15 UTC [SEC Form 8-K] [Bio-Path Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/bio-path-holdings-inc-filed-sec-form-8-k-regulation-fd-disclosure-5951517)
- 2025-03-18 11:00 UTC [Bio-Path Holdings Announces Pre-Clinical Results Signaling Increased Potential for BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients](https://www.quantisnow.com/insight/bio-path-holdings-announces-pre-clinical-results-signaling-increased-potential-for-bp1001-a-5948548)
- 2025-03-07 22:00 UTC [SEC Form 8-K] [Bio-Path Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits](https://www.quantisnow.com/insight/bio-path-holdings-inc-filed-sec-form-8-k-entry-into-a-5933974)
- 2025-02-18 12:00 UTC [SEC Form 8-K] [Bio-Path Holdings Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/bio-path-holdings-inc-filed-sec-form-8-k-notice-of-delisting-5892779)
- 2025-02-13 21:01 UTC [Bio-Path Holdings Expands Global Patent Portfolio](https://www.quantisnow.com/insight/bio-path-holdings-expands-global-patent-portfolio-5887309)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/BPTH
- Earnings history: https://www.quantisnow.com/earnings/BPTH
- Dividend history: https://www.quantisnow.com/dividends/BPTH
- Insider transactions: https://www.quantisnow.com/insiders/BPTH
- Options chain: https://www.quantisnow.com/options/BPTH
- SEC 8-K filings only: https://www.quantisnow.com/company/BPTH/8-k
- RSS and alerts for BPTH: https://www.quantisnow.com/docs/rss-feeds.md